Express Scripts in $3B contract dispute with Anthem; Pfizer wins again in ex-employees severance lawsuit;

@FiercePharma: Will pharma marketing to Hispanics finally gain traction in 2016? FiercePharmaMarketing story | Follow @FiercePharma

@EricPFierce: Bayer's new plant in China will make both traditional Chinese meds and western OTC meds. FiercePharmaManufacturing report | Follow @EricPFierce

> Express Scripts ($ESRX) faces the loss of its biggest client, Anthem ($ANTM), which is looking to benefit from lower market prices for drugs, particularly generics. Report

> Pfizer ($PFE) won its appeal in a court fight with ex-Wyeth employees that were angling for severance benefits even though they were rehired immediately after the merger. Report

> Sanofi's ($SNY) Korean unit and LG Life Sciences are locked in a dispute over a co-promotion deal on LG's top diabetes meds. Report

> Antidepressant treatment helps diabetics control their blood sugar, a new study found, potentially spurring more patients with both disorders to seek treatment. Report

Medical Device News

@FierceMedDev: ICYMI yesterday: Medtronic earns CE mark to use its drug-eluting balloon to help hemodialysis patients. Article | Follow @FierceMedDev

@EmilyWFierce: Zoetis slammed with up to $45M charge after EU ruling on Belgian tax scheme. FierceAnimalHealth story | Follow @EmilyWFierce

> In a win for LivaNova, the FDA approves the world's only sutureless aortic valve. Article

Biotech News

@FierceBiotech: BU group spotlights a lethal cascade that leads to Parkinson's. FierceBiotechResearch story | Follow @FierceBiotech

@JohnCFierce: When has Pfizer ever won an R&D marathon in the last decade? | Follow @JohnCFierce

> BioLineRx joins Merck's clique of immuno-oncology partners. Story

> Allergan's pipeline doesn't get enough respect, if you ask Pfizer. More

> Ysios, J&J back €11.5M round in Aelix to fund trials of HIV treatment. Article

Pharma Marketing News

> Will pharma marketing to Hispanics finally gain traction in 2016? More

> To flip the pricing debate, Big Pharma needs to tell some secrets. Story

> Look out, CLL. AbbVie and Roche's new venetoclax is on FDA's priority track. More

> Can Shire make the most of Baxalta's hemophilia meds? Item

> GSK's Slaoui sees 'major' vaccine market disruption for Merck as shingles candidate progresses. Article

Biotech Research News

> Cold Spring Harbor scientists develop a new drug for breast cancer. Report

> Johns Hopkins flags another possible successor to 'Special K' for depression. Story

> BU group spotlights a lethal cascade that leads to Parkinson's. More

> Slashing p75 neurotrophin receptor reduces obesity in mice: Gladstone. Article

> EPFL team creates an industrial-scale platform for stem cells. Item

Vaccines News

> Nearly a year into Novartis integration, GSK CEO won't discount vaccines spinoff. Report

> Aimmune takes peanut allergy vaccine into PhIII. More

> WHO seeks to ease cholera vaccine shortage with EuBiologics approval. Story

> Deal in Russia could cause Pfizer, GSK to lose contracts. Item

> New HIV vaccine player Aelix Therapeutics hits the scene with $12.7M Series A. Article

And Finally... Kids with Type 1 diabetes are finding comfort in American Girl dolls styled as diabetics. Report